Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma.

Autor: Araujo LF; Department of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil.; Medical Genomics Laboratory, CIPE, AC Camargo Cancer Center, São Paulo, Brazil., Siena ADD; Department of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil., Plaça JR; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil., Brotto DB; Department of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil., Barros II; Department of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil., Muys BR; Department of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil., Biagi CAO Jr; Department of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil., Peronni KC; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil., Sousa JF; Department of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil., Molfetta GA; Department of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil., West LC; Microbial Pathogenesis & Immunology, Health Science Center, Texas A&M University, College Station, USA., West AP; Microbial Pathogenesis & Immunology, Health Science Center, Texas A&M University, College Station, USA., Leopoldino AM; Department of Clinical Analysis-Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Espreafico EM; Department of Cellular and Molecular Biology-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Silva WA Jr; Department of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. wilsonjr@usp.br.; National institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil. wilsonjr@usp.br.; Center for Integrative System Biology-CISBi-NAP/USP, University of São Paulo, Ribeirão Preto, Brazil. wilsonjr@usp.br.

Publikováno v: Scientific reports [Sci Rep] 2018 Sep 21; Vol. 8 (1), pp. 14190. Date of Electronic Publication: 2018 Sep 21.